PORTUGAL: New subnational monthly data !
Have fun with OEC Games!
New 50% OFF discount for academic accounts !
Sign In
Pricing

300341 (Harmonized System 2017 for 6-digit)

2022
World Trade $11.5MRnk 5180 / 5380
2022
Top Exporter | Top Importer $7.4M | $7.39MChina | Japan
2022
Product Complexity -0.65Rnk 3977 / 5381
2021 - 2022
Export Growth (CAGR) 8.44%Rnk 2164 / 5380
2022
Share of World Trade <0.01%Rnk 5180 / 5380

About

Overview This page contains the latest trade data of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale. In 2022, Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were the world's 5180th most traded product, with a total trade of $11.5M. Between 2021 and 2022 the exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale grew by 8.44%, from $10.6M to $11.5M. Trade in Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale represent 0.000048% of total world trade.

Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale are a part of Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two....

Exports In 2022 the top exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale  were China ($7.4M), India ($1.27M), France ($513k), Netherlands ($418k), and Japan ($300k).

Imports In 2022 the top importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($7.39M), United States ($1.16M), Finland ($516k), Belgium ($477k), and Netherlands ($340k).

Ranking Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale ranks 3977th in the Product Complexity Index (PCI).

Latest Trends

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)China$7.4M
Top Destination (2022)Japan$7.39M

In 2022 Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were the world's 5180th most traded product (out of 5,380).

In 2022, the top exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were China ($7.4M), India ($1.27M), France ($513k), Netherlands ($418k), and Japan ($300k).

In 2022, the top importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($7.39M), United States ($1.16M), Finland ($516k), Belgium ($477k), and Netherlands ($340k).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2022)
[Click to Select a Country]

Importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2021 -  2022)China$1.14M
Top Destination Growth (2021 -  2022)Japan$1.13M

Between 2021 and 2022, the exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale grew the fastest in China ($1.14M), Netherlands ($397k), Tanzania ($299k), Egypt ($292k), and Malaysia ($248k).

Between 2021 and 2022, the fastest growing importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($1.13M), Belgium ($474k), Zambia ($292k), Netherlands ($240k), and Libya ($169k).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2021 - 2022)

Importers of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale (2021 - 2022)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale.

In 2022, market concentration measured using Shannon Entropy, was 2.09. This means that most of the exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale are explained by 4 countries.

Explore Visualizations

Value of Exports in Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale

Net Trade

TOP NET EXPORTER (2022)China$7.4M
TOP NET IMPORTER (2022)Japan$7.09M

This map shows which countries export or import more of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale. Each country is colored based on the difference in exports and imports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were China ($7.4M), India ($1.27M), France ($513k), Italy ($297k), and Egypt ($292k).

In 2022, the countries that had a largest trade value in imports than in exports of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale were Japan ($7.09M), United States ($943k), Belgium ($476k), Denmark ($133k), and Nigeria ($106k).

Net Trade (2022)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale.
It is possible to select the main countries that export or import Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Medicaments; containing alkaloids or their derivatives, containing ephedrine or its salts, not packaged for retail sale by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms